Assignee
NIHON MEDIPHYSICS CO LTD
JP·115 granted patents·59 pending applications·1,688 citations·filing 1978–2023
Top patents by PatentIndex Score
174 records- 0194US4923088ARadiation-shielding containerNIHON MEDIPHYSICS CO LTD·Filed 1988·Granted May 8, 1990·51 cites·6 claims
- 0293US5681529ABiological fluid analyzing deviceNIHON MEDIPHYSICS CO LTD·Filed 1995·Granted Oct 28, 1997·283 cites·25 claims
- 0392US4849207APorphyrin derivativesNIHON MEDIPHYSICS CO LTD·Filed 1986·Granted Jul 18, 1989·50 cites·17 claims
- 0491US7910745B2Organic compound and method for producing radioactive halogen-labeled organic compound using the sameNIHON MEDIPHYSICS CO LTD·Filed 2006·Granted Mar 22, 2011·10 cites·16 claims
- 0590US7897811B2Process for production of radioactive fluorine-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2007·Granted Mar 1, 2011·6 cites·5 claims
- 0690US5071636AChelating compounds and their useNIHON MEDIPHYSICS CO LTD·Filed 1988·Granted Dec 10, 1991·34 cites·10 claims
- 0789US4996312APorphyrin derivatives, and their production and useNIHON MEDIPHYSICS CO LTD·Filed 1989·Granted Feb 26, 1991·29 cites·5 claims
- 0888US8343459B2Method for production of radiation diagnostic imaging agentNIHON MEDIPHYSICS CO LTD·Filed 2008·Granted Jan 1, 2013·7 cites·5 claims
- 0988US6607710B1Bisphosphonic acid derivative and compound thereof labeled with radioactive nuclideNIHON MEDIPHYSICS CO LTD·Filed 2000·Granted Aug 19, 2003·28 cites·24 claims
- 1086US10010632B2Precursor compound of radioactive halogen-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2015·Granted Jul 3, 2018·2 cites·2 claims
- 1186US4855353AHigh molecular compounds having amino groups, and their utilizationNIHON MEDIPHYSICS CO LTD·Filed 1987·Granted Aug 8, 1989·61 cites·19 claims
- 1282US8022207B2Compound having affinity to amyloidNIHON MEDIPHYSICS CO LTD·Filed 2007·Granted Sep 20, 2011·5 cites·8 claims
- 1381US9381259B2Precursor compound of radioactive halogen-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2014·Granted Jul 5, 2016·1 cites·4 claims
- 1481US4440739ARadioactive diagnostic agent and non-radioactive carrier thereforNIHON MEDIPHYSICS CO LTD·Filed 1981·Granted Apr 3, 1984·12 cites·12 claims
- 1576US9387266B2Precursor compound of radioactive halogen-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2015·Granted Jul 12, 2016·1 cites·5 claims
- 1676US5764356ATrace liquid detecting and analyzing deviceNIHON MEDIPHYSICS CO LTD·Filed 1996·Granted Jun 9, 1998·52 cites·11 claims
- 1776US2021386873A1Precursor compound of radioactive halogen-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2021·Application pending·0 cites
- 1875US12046385B2Production method of 226Ra target, production method of 225Ac, and electrodeposition solution for producing 226Ra targetNIHON MEDIPHYSICS CO LTD·Filed 2020·Granted Jul 23, 2024·1 cites·13 claims
- 1974US11083804B2Precursor compound of radioactive halogen-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2018·Granted Aug 10, 2021·0 cites·10 claims
- 2074US10953112B2Precursor compound of radioactive halogen-labeled organic compoundNIHON MEDIPHYSICS CO LTD·Filed 2020·Granted Mar 23, 2021·0 cites·4 claims
- 2172US2023364275A1METHOD FOR PRODUCING Ac-225 SOLUTION AND METHOD FOR PRODUCING MEDICINE USING Ac-225 SOLUTIONNIHON MEDIPHYSICS CO LTD·Filed 2023·Application pending·0 cites
- 2270US11752223B2Method for producing Ac-225 solution and method for producing medicine using Ac-225 solutionNIHON MEDIPHYSICS CO LTD·Filed 2022·Granted Sep 12, 2023·0 cites·5 claims
- 2370US11551826B2Method for producing 225AcNIHON MEDIPHYSICS CO LTD·Filed 2022·Granted Jan 10, 2023·0 cites·9 claims
- 2470US5759866ADevice and method for assaying biological components in sampleNIHON MEDIPHYSICS CO LTD·Filed 1996·Granted Jun 2, 1998·38 cites·16 claims
- 2568US9107964B2Radioactive fluorine-labeled compoundNIHON MEDIPHYSICS CO LTD·Filed 2012·Granted Aug 18, 2015·1 cites·9 claims
- 2668US7445765B2Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplexNIHON MEDIPHYSICS CO LTD·Filed 2001·Granted Nov 4, 2008·3 cites·5 claims
- 2768US5032678ARadio labeled high molecular compound comprising unit of asialoglycoprotein acceptor-directing compound and unit of chelate forming compound chemically bonded theretoNIHON MEDIPHYSICS CO LTD·Filed 1987·Granted Jul 16, 1991·28 cites·6 claims
- 2868US4313928AComposition for labeling of red blood cells with radioactive technetiumNIHON MEDIPHYSICS CO LTD·Filed 1979·Granted Feb 2, 1982·18 cites·4 claims
- 2968US4287362A2-Oxopropionaldehyde bis(thiosemicarbazone) derivativesNIHON MEDIPHYSICS CO LTD·Filed 1980·Granted Sep 1, 1981·22 cites·4 claims
- 3067US7029653B1Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the methodNIHON MEDIPHYSICS CO LTD·Filed 2000·Granted Apr 18, 2006·5 cites·13 claims
- 3167US5611785ALuer needle unit and injectorNIHON MEDIPHYSICS CO LTD·Filed 1995·Granted Mar 18, 1997·135 cites·8 claims
- 3267US5250702ADiethylenetriamine pentaacetic acid derivativesNIHON MEDIPHYSICS CO LTD·Filed 1991·Granted Oct 5, 1993·10 cites·5 claims
- 3367US4489053AStable radioactive diagnostic agent and a non-radioactive carrier thereforNIHON MEDIPHYSICS CO LTD·Filed 1982·Granted Dec 18, 1984·25 cites·4 claims
- 3467US4425319ARadioactive diagnostic agent and non-radioactive carrier thereforNIHON MEDIPHYSICS CO LTD·Filed 1981·Granted Jan 10, 1984·28 cites·22 claims
- 3567US4338248A2-Oxopropionaldehyde bis(thiosemicarbazone) protein derivatives, and their production and useNIHON MEDIPHYSICS CO LTD·Filed 1980·Granted Jul 6, 1982·21 cites·12 claims
- 3666US12179149B2Method for purifying 226Ra-containing solution, method for producing 226Ra target, and method for producing 225AcNIHON MEDIPHYSICS CO LTD·Filed 2020·Granted Dec 31, 2024·0 cites·9 claims
- 3766US4645660AIncreasing labeling efficiency by forming diagnostic agent in the presence of ascorbic acid or the likeNIHON MEDIPHYSICS CO LTD·Filed 1984·Granted Feb 24, 1987·24 cites·8 claims
- 3865US7045115B2Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseasesNIHON MEDIPHYSICS CO LTD·Filed 2002·Granted May 16, 2006·4 cites·6 claims
- 3964US5274082AParamagnetic complexes of chelating compoundsNIHON MEDIPHYSICS CO LTD·Filed 1992·Granted Dec 28, 1993·9 cites·3 claims
- 4063US7220827B2Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredientNIHON MEDIPHYSICS CO LTD·Filed 2003·Granted May 22, 2007·2 cites·11 claims
- 4163US5271924ALow molecular weight polysaccharide complexes for nuclear magnetic resonance imagingNIHON MEDIPHYSICS CO LTD·Filed 1992·Granted Dec 21, 1993·22 cites·8 claims
- 4262US2022328208A1PRODUCTION METHOD OF 225AcNIHON MEDIPHYSICS CO LTD·Filed 2022·Application pending·0 cites
- 4361US12569578B2RI-labeled humanized antibodyNIHON MEDIPHYSICS CO LTD·Filed 2022·Granted Mar 10, 2026·0 cites·22 claims
- 4461US5770178AMetal chelate forming peptides and use thereofNIHON MEDIPHYSICS CO LTD·Filed 1995·Granted Jun 23, 1998·22 cites·14 claims
- 4561US2008267868A1Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplexNIHON MEDIPHYSICS CO LTD·Filed 2007·Application pending·0 cites
- 4661US2024084419A1RECOVERY METHOD OF Ra-226, PRODUCTION METHOD OF Ra-226 SOLUTION, AND PRODUCTION METHOD OF Ac-225 SOLUTIONNIHON MEDIPHYSICS CO LTD·Filed 2021·Application pending·0 cites
- 4761US2026021213A1Method for producing fc-containing molecule modifying reagentNIHON MEDIPHYSICS CO LTD·Filed 2023·Application pending·0 cites
- 4860US5904915AMethod of diagnosing pathological state of tumor cells using a diagnostic agent for glycometabolic functionNIHON MEDIPHYSICS CO LTD·Filed 1997·Granted May 18, 1999·18 cites·5 claims
- 4960US2025177583A1Method for producing complexNIHON MEDIPHYSICS CO LTD·Filed 2023·Application pending·0 cites
- 5059US9424642B2Extraction of myocardial contour pointsNIHON MEDIPHYSICS CO LTD·Filed 2014·Granted Aug 23, 2016·1 cites·24 claims
Showing the top 50 of 174 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →